WhiteHawk identifies key business security trends


Published 07-SEP-2018 10:05 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

WhiteHawk Limited (ASX:WHK) has indicated that it continues to discover crucial analytics when executing a 360 Cyber Risk Framework contract for small-to-medium business (SME).

The implementation of the company’s Cyber 360 Risk Framework spans across six different industries: business services, finance, insurance, retail, technology and transportation.

Data collected by WHK shows that the majority of SMEs have concerning cyber security gaps that put the entity at risk. Continued monitoring of the company’s cyber risks is a critical component to the organisation’s resilience to fraud and cyber-attacks.

Interestingly, 60% of the companies who received a cyber risk rating from WHK required risk mitigation.

Due to the initial roll out of the Cyber 360 Risk Framework, WHK has identified email as the top vulnerability in SMEs, which are prone to poor cyber hygiene.

As part of the ongoing Cyber 360 Risk Framework, the company will provide each company with a unique Cyber Risk Profile that maps out current risks and provides recommended actions and products to address key weaknesses.

WHK Executive Chair Terry Roberts spoke on the update, “Demonstrating real time cyber risk monitoring and mitigation across hundreds of supply chain companies or vendors is powerful and measurable.

“It puts affordable and transparent cyber security risk ratings and continuous improvement in the hands of company executives, boards and shareholders,” she said.

Of course, as with all emerging WHK remains a speculative stock and investors should consider their own personal circumstances before investing, and seek professional financial advice.

The company expects the Framework to grow and is eyeing continued expansion that could cover hundreds of supply chain companies for a single contract engagement.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free